Molecular signature linked to acute phase injury and tumor invasiveness in small-for-size liver grafts

Annals of Surgery

Volumn 251, Issue 6, 2010, Pages 1154-1161

  Man, Kwan ^a   Co Shih, Kendrick ^a   Ng, Kevin T P ^a   Xiao, Jiang Wei ^a   Guo, Dong Yong ^a   Sun, Chris K W ^a   Lim, Zophia X H ^a   Cheng, Qiao ^a   Liu, Yan ^a   Fan, Sheung Tat ^a   Mau Lo, Chung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; DNA MICROARRAY; DRUG TARGETING; GENE OVEREXPRESSION; GRAFT DYSFUNCTION; GRAFT INJURY; GRAFT RECIPIENT; GRAFT SIZE; HEPATOMA CELL; IN VITRO STUDY; INJECTION; LIVER CANCER; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACUTE-PHASE REACTION; ANIMALS; CELL LINE, TUMOR; CHEMOKINE CXCL10; GENE EXPRESSION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MACROPHAGES; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; RATS; RATS, INBRED BUF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 77953022144     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181d96e3d     Document Type: Article

References (23)

1. Fisher RA, Kulik LM, Freise CE, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007;7:1601-1608.
2. Yang ZF, Poon RT, Luo Y, et al. Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. J Immunol. 2004; 173:2507-2515.
3. Man K, Lo CM, Xiao JW, et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg. 2008;247:1049-1057.
4. Man K, Ng KT, Lo CM, et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases\activation of cell invasion and migration pathways. Liver Transpl. 2007;13:1669-1677.
5. Man K, Zhao Y, Xu A, et al. Fat-derived hormone adiponectin combined with FTY720 significantly improves small-for-size fatty liver graft survival. Am J Transplant. 2006;6:467-476.
6. Ng KT, Man K, Ho JW, et al. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway. Int J Oncol. 2007;30:375-380.
7. Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg. 2001;136:280-285.
8. Man K, Lo CM, Lee TK, et al. Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl. 2003;9:425-432.
9. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg. 2003;237:256-264.
10. Sellaro TL, Ravindra AK, Stolz DB, et al. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 2007;13:2301-2310.
11. Lee TK, Man K, Ho JW, et al. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res. 2005;11:8458-8466.
12. Sun CK, Man K, Ng KT, et al. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis. 2008;29:2096-2105.
13. Lee TK, Man K, Poon RT, et al. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res. 2006; 66:9948-9956.
14. Zipin-Roitman A, Meshel T, Sagi-Assif O, et al. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 2007;67: 3396-3405.
15. Sato E, Fujimoto J, Toyoki H, et al. Expression of IP-10 related to angio-genesis in uterine cervical cancers. Br J Cancer. 2007;96:1735-1739.
16. Mejlvang J, Kriajevska M, Berditchevski F, et al. Characterization of E-cadherin-dependent and-independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Exp Cell Res. 2007;313:380-393.
17. Sherwood DR, Butler JA, Kramer JM, et al. FOS-1 promotes basement-membrane removal during anchor-cell invasion in C. elegans. Cell. 2005; 121:951-962.
18. Wegiel B, Bjartell A, Culig Z, et al. Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer. 2008;122:1521-1529.
19. Hofmann HS, Hansen G, Richter G, et al. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res. 2005;11:1086-1092.
20. Luk JM, Lam CT, Siu AF, et al. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics. 2006;6:1049-1057.
21. Yang X, Chu Y, Wang Y, et al. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. J Leukoc Biol. 2006;80:1434-1444.
22. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605-612.
23. Bowden ET, Onikoyi E, Slack R, et al. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res. 2006;312:1240-1253.